The Palmoplantar Pustulosis Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Palmoplantar Pustulosis Market?
The size of the palmoplantar pustulosis market has been increasing substantially in the past few years. The market size is projected to rise from $1.93 billion in 2024 to $2.10 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 8.3%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Palmoplantar Pustulosis Industry?
The 2029 market projections for the palmoplantar pustulosis market forecast a strong growth rate. The market size is anticipated to reach $2.84 billion in 2029, growing at a compound annual growth rate (CAGR) of 7.9%.
Download Your Free Sample of the 2025 Palmoplantar Pustulosis Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Palmoplantar Pustulosis Market?
The key drivers in the palmoplantar pustulosis market are:
• Rising adoption of biologic therapies
• Increasing investments in dermatology research
• Growing pipeline of novel treatments
• Rising demand for personalized medicine
Global Market Segmentation: Identifying Major Palmoplantar Pustulosis Industry Segments
The palmoplantar pustulosis market covered in this report is segmented –
1) By Treatment Type: Topical Treatments, Systemic Treatments, Biologics, Phototherapy
2) By Application: Hospitals, Dermatology Clinics, Homecare Settings
3) By Distribution Channel: Online Pharmacies, Retail Pharmacies, Hospitals
Subsegments:
1) By Topical Treatments: Corticosteroids, Vitamin D Analogues, Calcineurin Inhibitors, Keratolytics
2) By Systemic Treatments: Retinoids, Immunosuppressants, Phosphodiesterase-4 (PDE4) Inhibitors, Corticosteroids
3) By Biologics: Tumor Necrosis Factor (TNF) Inhibitors, Interleukin-17 (IL-17) Inhibitors, Interleukin-23 (IL-23) Inhibitors, Interleukin-12/23 (IL-12/23) Inhibitors
4) By Phototherapy: Narrowband UVB Therapy (NB-UVB), Psoralen plus Ultraviolet A (PUVA) Therapy, Excimer Laser Therapy, Targeted Phototherapy
Pre-order the 2025 Palmoplantar Pustulosis Global Market Report for Fast Delivery & Comprehensive Insights!
What are the emerging Trends Shaping the Future of the Palmoplantar Pustulosis Market?
The key trends in the palmoplantar pustulosis market are:
• The trend towards the adoption of biologic therapies and immunomodulators is shaping the future of the Palmoplantar Pustulosis market.
• Development of advanced topical formulations is an emerging trend in the market.
• There is an increasing trend towards the integration of artificial intelligence in dermatological diagnosis.
• The use of machine learning in dermatological research is also a rising trend in the market.
Who Are the Top Competitors & Leading Players in the Palmoplantar Pustulosis Market?
Major players in the palmoplantar pustulosis market are:
• Pfizer Inc.
• AbbVie Inc.
• Sanofi S.A.
• Bristol-Myers Squibb Company
• Novartis International AG
• GlaxoSmithKline PLC (GSK)
• Amgen Inc.
• C.H. Boehringer Sohn AG & Co. KG
• Bausch Health Companies Inc.
• Chugai Pharmaceutical Co. Ltd.
• Janssen Pharmaceuticals Inc.
• Kyowa Kirin Co. Ltd.
• Swedish Orphan Biovitrum AB (Sobi)
• Almirall S.A.
• MorphoSys AG
• MoonLake Immunotherapeutics AG
• Aristea Therapeutics Inc.
• AnaptysBio Inc.
• Taiho Pharmaceutical Co. Ltd.
• Kamari Pharma Ltd.
Regional Dominance: Which Area Leads the Global Template Market?
North America was the largest region in the palmoplantar pustulosis market in 2024
